Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
Johnson and Johnson

Last Updated: June 3, 2023

Hikma Pharms Company Profile

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What is the competitive landscape for HIKMA PHARMS, and what generic and branded alternatives to HIKMA PHARMS drugs are available?

HIKMA PHARMS has thirty-six approved drugs.

There are two tentative approvals on HIKMA PHARMS drugs.

Summary for Hikma Pharms
US Patents:0

Drugs and US Patents for Hikma Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma Pharms DICYCLOMINE HYDROCHLORIDE dicyclomine hydrochloride TABLET;ORAL 040161-001 Oct 1, 1996 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Hikma Pharms ESCITALOPRAM OXALATE escitalopram oxalate TABLET;ORAL 078766-003 Sep 11, 2012 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Hikma Pharms GLIMEPIRIDE glimepiride TABLET;ORAL 078952-001 Aug 1, 2013 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Hikma Pharms CEPHALEXIN cephalexin FOR SUSPENSION;ORAL 065444-002 Aug 28, 2009 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Hikma Pharms BUPIVACAINE HYDROCHLORIDE bupivacaine hydrochloride INJECTABLE;INJECTION 205141-001 Feb 11, 2021 AP RX No No ⤷  Try a Trial ⤷  Try a Trial
Hikma Pharms PARICALCITOL paricalcitol SOLUTION;INTRAVENOUS 205917-001 Nov 18, 2014 AP RX No No ⤷  Try a Trial ⤷  Try a Trial
Hikma Pharms ISOSORBIDE MONONITRATE isosorbide mononitrate TABLET;ORAL 075361-001 Oct 5, 2000 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.